D. E. Shaw & Co., Inc. - AKEBIA THERAPEUTICS INC ownership

AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 151 filers reported holding AKEBIA THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of AKEBIA THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$16,000
-51.5%
22,547
+56.7%
0.00%
Q4 2021$33,000
-97.2%
14,393
-96.5%
0.00%
-100.0%
Q4 2020$1,166,000
-77.1%
416,583
-79.5%
0.00%
-80.0%
Q3 2020$5,096,000
-83.8%
2,030,370
-12.6%
0.01%
-86.8%
Q2 2020$31,530,000
+217.0%
2,321,807
+77.0%
0.04%
+137.5%
Q1 2020$9,945,000
+99.8%
1,311,965
+66.6%
0.02%
+166.7%
Q4 2019$4,978,000
+210.5%
787,631
+92.6%
0.01%
+200.0%
Q3 2019$1,603,000
-37.1%
409,043
-22.3%
0.00%
-33.3%
Q2 2019$2,549,000
-11.5%
526,592
+49.7%
0.00%
-25.0%
Q1 2019$2,881,000
+24.9%
351,787
-15.7%
0.00%
+33.3%
Q4 2018$2,307,000
+148.9%
417,178
+297.4%
0.00%
+200.0%
Q3 2018$927,000
+16.8%
104,971
+31.9%
0.00%0.0%
Q2 2018$794,000
+162.9%
79,575
+150.9%
0.00%
Q1 2018$302,000
-60.5%
31,714
-38.2%
0.00%
-100.0%
Q4 2017$764,000
-61.1%
51,349
-48.6%
0.00%
-66.7%
Q3 2017$1,966,000
+568.7%
99,937
+388.0%
0.00%
Q2 2017$294,000
+94.7%
20,478
+41.5%
0.00%
Q4 2016$151,000
-28.4%
14,477
-38.0%
0.00%
Q3 2016$211,000
+15.3%
23,359
-4.6%
0.00%
Q2 2016$183,000
-26.8%
24,485
-11.6%
0.00%
Q1 2016$250,000
+47.1%
27,700
+89.9%
0.00%
Q4 2014$170,00014,5840.00%
Other shareholders
AKEBIA THERAPEUTICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Alerce Investment Management, L.P. 4,652,561$13,027,0005.13%
Orchard Capital Management, LLC 857,138$2,400,0001.02%
Nantahala Capital Management 7,040,487$19,713,0000.61%
OCCUDO QUANTITATIVE STRATEGIES LP 209,040$585,0000.18%
Woodline Partners LP 2,382,522$6,671,0000.18%
RICE HALL JAMES & ASSOCIATES, LLC 1,546,169$4,329,0000.15%
Virtus ETF Advisers LLC 92,771$260,0000.11%
Jump Financial, LLC 155,583$435,0000.07%
GSA CAPITAL PARTNERS LLP 128,626$360,0000.06%
Anson Funds Management LP 95,342$267,0000.05%
View complete list of AKEBIA THERAPEUTICS INC shareholders